Chest computed tomography findings for a cohort of children with pulmonary Langerhans cell histiocytosis.


Journal

Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624

Informations de publication

Date de publication:
10 2020
Historique:
received: 19 03 2020
revised: 19 05 2020
accepted: 25 05 2020
pubmed: 28 7 2020
medline: 5 1 2021
entrez: 26 7 2020
Statut: ppublish

Résumé

This study was undertaken to describe the spectrum of lung computed-tomography (CT) findings in children with pulmonary Langerhans cell histiocytosis (PLCH) and to evaluate for this population the CT-scan nodule and cyst scores proposed by adult pulmonologists at diagnosis and during follow-up. Among 175 children with PLCH identified in the French national population-based Langerhans cell histiocytosis cohort, 60 were retrospectively selected by the availability of CT for a central review by three pediatric radiologists. These 60 patients are representative of childhood PLCH for almost all clinical aspects, except a lower percentage of risk organ involvement (38% vs 54%; P = 0.05). The 60 children's chest CT scans (n = 218) were reviewed. At diagnosis, 63% of them had nodules, 53% had cysts, and 29% had both. The percentages of patients with nodules or cysts increased from diagnosis to peak disease activity, respectively, from 63% to 73% and from 53% to 66%. The costophrenic angle was involved in 71%. Patients with pneumothorax (25%) had a higher median cyst score. Alveolar consolidation was observed in 34%. Patients with low CT-scan nodule and cyst scores had no long-term pulmonary sequelae. Well-known characteristics of adult PLCH (nodules and cysts) were observed in children. The chest CT scores proposed by adult pulmonologists could easily be applied to childhood PLCH. Lesions in children, unlike those in adults, are frequently located near the costophrenic angles. Alveolar consolidation might be considered an atypical feature of childhood PLCH.

Identifiants

pubmed: 32710685
doi: 10.1002/pbc.28496
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e28496

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Collin M, Bigley V, McClain KL, Allen CE. Cell(s) of origin of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 2015;29:825-838.
Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans' cell histiocytosis. Thorax. 2000;55:405-416.
Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med. 2000;342:1969-1978.
Haupt R, Minkov M, Astigarraga I, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60:175-184.
Tazi A, de Margerie C, Naccache JM, et al. The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study. Orphanet J Rare Dis. 2015;10:30.
Vassallo R, Harari S, Tazi A. Current understanding and management of pulmonary Langerhans cell histiocytosis. Thorax. 2017;72:937-945.
Braier J, Latella A, Balancini B, et al. Isolated pulmonary langerhans cell histiocytosis presenting with recurrent pneumothorax. Pediatr Blood Cancer. 2007;48:241-244.
Odame I, Li P, Lau L, et al. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood. Pediatr Blood Cancer. 2006;47:889-893.
Ronceray L, Potschger U, Janka G, et al. Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome. J Pediatr. 2012;161:129-133.
Seely JM, Salahudeen S Sr, Cadaval-Goncalves AT, et al. Pulmonary Langerhans cell histiocytosis: a comparative study of computed tomography in children and adults. J Thorac Imaging. 2012;27:65-70.
Wang D, Cui L, Li ZG, et al. Clinical research of pulmonary Langerhans cell histiocytosis in children. Chin Med J (Engl). 2018;131:1793-1798.
Canuet M, Kessler R, Jeung MY, et al. Correlation between high-resolution computed tomography findings and lung function in pulmonary Langerhans cell histiocytosis. Respiration. 2007;74:640-646.
Tazi A, Marc K, Dominique S, et al. Serial computed tomography and lung function testing in pulmonary Langerhans' cell histiocytosis. Eur Respir J. 2012;40:905-912.
Rigaud C, Barkaoui MA, Thomas C, et al. Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age. Br J Haematol. 2016;174:887-898.
Guyot-Goubin A, Donadieu J, Barkaoui M, et al. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer. 2008;51:71-75.
Hansell DM. High-resolution computed tomography and diffuse lung disease. J R Coll Physicians Lond. 1999;33:525-531.
Hansell DM, Bankier AA, Macmahon HE, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2016;246:697-722.
Vo P, Kharasch VS. Respiratory failure. Pediatr Rev. 2014;35:476-484.
Ducassou S, Seyrig F, Thomas C, et al. Thymus and mediastinal node involvement in childhood Langerhans cell histiocytosis: long-term follow-up from the French national cohort. Pediatr Blood Cancer. 2013;60:1759-1765.
Brauner MW, Grenier P, Tijani K, et al. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology. 1997;204:497-502.
Ko SM, Choe BK, Kim HS, et al. Atypical radiological manifestations of pulmonary Langerhans cell histiocytosis in a 12-year-old girl. Br J Radiol. 2008;81:e238-e241.
Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med. 2002;346:484-490.
Brauner MW, Grenier P, Mouelhi MM, et al. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology. 1989;172:255-258.
Soler P, Chollet S, Jacque C, et al. Immunocytochemical characterization of pulmonary histiocytosis X cells in lung biopsies. Am J Pathol. 1985;118:439-451.
Vassallo R, Jensen EA, Colby TV, et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest. 2003;124:1199-1205.
Kambouchner M, Emile JF, Copin MC, et al. Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAF(V600E) mutation study from the French national cohort. Hum Pathol. 2019;89:51-61.
Heritier S, Emile JF, Barkaoui MA, et al. BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy. J Clin Oncol. 2016;34:3023-3030.
Bano S, Chaudhary V, Narula MK, et al. Pulmonary Langerhans cell histiocytosis in children: a spectrum of radiologic findings. Eur J Radiol. 2014;83:47-56.
Romei C, Turturici L, Tavanti L, et al. The use of chest magnetic resonance imaging in interstitial lung disease: a systematic review. Eur Respir Rev. 2018;27:180062.
Sodhi KS, Sharma M, Lee EY, et al. Diagnostic utility of 3T lung MRI in children with interstitial lung disease: a prospective pilot study. Acad Radiol. 2018;25:380-386.

Auteurs

Valeria Della Valle (V)

Pediatric Radiology Department, Assistance Publique-Hopitaux de Paris (APHP), Trousseau Hospital, Paris, France.
Sorbonne Université, Paris, France.

Jean Donadieu (J)

French Referral Center for Langerhans' Cell Histiocytosis, APHP, Trousseau Hospital, Paris, France.

Chiara Sileo (C)

Pediatric Radiology Department, Assistance Publique-Hopitaux de Paris (APHP), Trousseau Hospital, Paris, France.

Mohamed Aziz Barkaoui (MA)

French Referral Center for Langerhans' Cell Histiocytosis, APHP, Trousseau Hospital, Paris, France.

Sébastien Héritier (S)

French Referral Center for Langerhans' Cell Histiocytosis, APHP, Trousseau Hospital, Paris, France.

Hervé Brisse (H)

Radiology Department, Institut Curie, Paris, France.

Nathalie Boutry (N)

Radiology Department, Jeanne-de-Flandre Hospital (CHRU), Lille, France.

Catherine Tréguier (C)

Radiology Department, Sud Hospital (CHU), Rennes, France.

Jean-François Chateil (JF)

Radiology Department, Pellegrin Hospital (CHU), Bordeaux, France.

Philippe Petit (P)

Radiology Department, La Timone Hospital (APHM), Marseille, France.

Jean-Pierre Pracros (JP)

Radiology Department, Pierre-Wertheimer Hospital (CHU), Lyon, France.

Pascal Chastagner (P)

Pediatric Hemato-Oncology, CHU de Nancy, Nancy, France.

Corinne Boyer (C)

Radiology Department, L'Archet Hospital (CHU), Nice, France.

Francis Veillon (F)

Radiology Department, Hautepierre Hospital (CHU), Strasbourg, France.

Chantal Durand (C)

Radiology Department, Couple Enfant Hospital (CHU), Grenoble, France.

Charbel Mounayer (C)

Radiology Department, CHU de Limoges, Limoges, France.

Marianne Kambouchner (M)

Pathology Department, APHP, Avicennes Hospital, Bobigny, France.

Michel Brauner (M)

Radiology Department, APHP, Avicennes Hospital, Bobigny, France.

Abdellatif Tazi (A)

Pneumology Department, French Referral Center for Langerhans Cell Histiocytosis, APHP, Trousseau Hospital, Paris, France.

Ralp Epaud (R)

Service de Pédiatrie Générale, Centre Hospitalier Intercommunal, Creteil, France.

Hubert Ducou le Pointe (H)

Pediatric Radiology Department, Assistance Publique-Hopitaux de Paris (APHP), Trousseau Hospital, Paris, France.
Sorbonne Université, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH